Abstract
Twenty-three patients (5 to 15 years of age) with primary nocturnal enuresis were treated with desmopressin (DDAVP) according to a four-step protocol with weekly reductions of daily doses (1 to 0.25 μg/kg body weight) thus including aspects of behavior-oriented “bladder retention training”. The rate of wet nights was significantly reduced while patients were on medication (p<0.02), but the sample as a whole returned to baseline levels after medication was stopped. Six subjects (26%) were non-responders. A variety of psychological and psychosocial single factors did not significantly affect the outcome. However, a subgroup of seven patients assessed as “psychologically non-distressed” revealed better results both on medication (p<0.02; reduction 73%) and off medication (p≥0.05; reduction 39%) compared to a “distressed” subgroup (N=16). Both groups showed significant changes in wet nights over the treatment course (p<0.02 and p≥ 0.002, respectively). There was no clear-cut relationship between laboratory data (urine volume, osmolality, vasopressin) and outcome in wet nights. Data did not suggest a subgroup of patients with particularly low nocturnal vasopressin (AVP) secretion and, thus, high rates of wet nights. Our results corroborated the finding that DDAVP is an effective substance in reducing wet nights in patients with primary nocturnal enuresis. However, with respect to major reductions and long-term results (off medication), these preliminary findings suggest that “psychological distress” seems to be a very important confounding outcome variable. Thus, careful consideration and assessment of psychological and psychosocial aspects of distress are recommended. Eventually, a combination of DDAVP treatment with counseling and/or psychotherapy may significantly improve results for the majority of patients and families.
Similar content being viewed by others
References
Aladjem M, Wohl R, Boichis H, Orda S, Lotan D, Freedman S (1982) Desmopressin in nocturnal enuresis. Archives of Disease in Childhood 57:137–140
American Psychiatric Association. (1987) Diagnostic and Statistical Manual of Mental Disorders. (Third Edition - Revised ed.). APA, Washington, DC
Belmaker RH, Bleich A (1986) The use of desmopressin in adult enuresis. Military Medicine 151:660–662
Birkasova M, Birkas O, Flynn MJ, Cort JH (1978) Desmopressin in the management of nocturnal enuresis in children: double-blind study. Pediatrics 62:970–974
Crawford JD (ed) (1989a) Treatment of nocturnal enuresis. Journal of Pediatrics 114 (Supplement):691–726
Crawford JD (1989b) Introductory comments. Journal of Pediatrics 114 (Supplement):687–690
De Wied D (1980) Hormonal influences on motivation, learning, memory and psychosis. In: Krieger DT (ed) Neuroendocrinology (pp. 194–204). Sinauer, Sunderland
Dimson SB (1977) Desmopressin as a treatment for enuresis. Lancet 1:1260
Dimson SB (1986) DDAVP and urine osmolality in refractory enuresis. Archives of Disease in Childhood 61:1104–1107
Dische S, Yule W, Corbett J, Hand D (1983). Childhood nocturnal enuresis: factors associated with outcome of treatment with an enuresis alarm. Developmental Medicine and Child Neurology 25:67–80
Evans JHC (1989) The efficacy of DDAVP in the treatment of nocturnal enuresis. In: Meadow SR (ed) Desmopressin in nocturnal enuresis (pp. 29–34). Horus Medical Publications, Canwell, England
Ferguson DM, Horwood LJ, Shannon FT (1986) Factors related to the age of attainment of nocturnal bladder control: an 8-year longitudinal study. Pediatrics 78:884–890
Ferrie BG, MacFarlane J, Glen ES (1984) DDAVP in young enuretic patients: a double-blind trial. British Journal of Urology 56:376–378
Forsythe WI, Butler RJ (1989) Fifty years of enuretic alarms. Archives of Disease in Childhood 64:879–885
Forsythe WI, Redmond A (1974). Enuresis and spontaneous cure rate. Study of 1129 enuretics. Archives of Disease in Childhood 49:259
Harris AS (1989) Clinical experience with desmopressin: efficacy and safety in central diabetes insipidus and other conditions. Journal of Pediatrics 114 (Supplement):711–718
Hilton P, Hertogs K, Stanton SL (1983) The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 46:854–855
Hilton P, Stanton SL (1982) The use of desmopressin (DDAVP) in nocturnal urinary frequency in the female. British Journal of Urology 54:252–255
Hjälmås K, Sillen U (1990) Pharmacological treatment of bed-wetting. Drug Investigation, 2 (Supplement 5):17–21
Kammerer E (1985) Enuresis. In: Remschmidt H, Schmidt MH (eds) Kinder- und Jugendpsychiatrie in Klinik und Praxis. Bd. III (pp. 83–95). Thieme, Stuttgart, New York
Klauber GT (1989) Clinical efficacy and safety of desmopressin in the treatment of nocturnal enuresis. Journal of Pediatrics 114 (Supplement):719–722
Knudsen UB, Rittig S, Nörgaard JP, Lundemose JB, Pedersen EB, Djurhuus JC (1991) Long-term treatment of nocturnal enuresis with desmopressin. Urology Research 19:237–240
Meadow SR (1989) Management of nocturnal enuresis. In: Meadow SR (ed) Desmopressin in nocturnal enuresis (pp. 16–21). Horus Medical Publications, Canwell, England
Mikkelson EJ, Rapoport JL (1980) Enuresis: Psychopathology, sleep stage, and drug response. Urologic Clinics of North America 7:361–377
Miller K, Goldberg S, Atkin B (1989) Nocturnal enuresis: experience with long-term use of intranasally administered desmopressin. Journal of Pediatrics 114 (Supplement):723–726
Moses AM (1980) Diabetes insipidus and ADH regulation. In: Krieger DT (ed) Neuroendocrinology (pp. 141–148). Sinauer, Sunderland
Nörgaard JP (1989a) Urodynamics in enuretics I: reservoir function. Neurourology and Urodynamics 8:199–211
Nörgaard JP (1989b) Urodynamics in enuretics II: a pressure/flow study. Neurourology and Urodynamics 8:213–217
Nörgaard JP, Rittig S (1989) Recent studies of the pathology of nocturnal enuresis. In: Meadow SR (ed) Desmopressin in nocturnal enuresis (pp. 11–15). Horus Medical Publications, Canwell, England
Nörgaard JP, Rittig S, Djurhuus JC (1989) Nocturnal enuresis: an approach to treatment based on pathogenesis. Journal of Pediatrics 114 (Supplement):705–710
Novello AC, Novello JR (1987) Enuresis. Pediatric Clinics of North America 34:719–733
Olness K (1975) The use of self-hypnosis in the treatment of childhood nocturnal enuresis. Clinical Pediatrics 14:273–279
Pedersen PS, Hejl M, Kjöller SS (1985) Desamino-D-arginine vasopressin in childhood nocturnal enuresis. Journal of Urology 133:65–66
Perlmutter AD (1985) Enuresis. In: Kelalis PP, King LR, Belman AB (eds) Clinical pediatric urology (Vol. 1, pp. 311–325). Saunders, Philadelphia London Toronto
Post EM, Richman RA, Blackett PR, Duncan KP, Miller K (1983) Desmopressin response of enuretic children. American Journal of Diseases of Children 137:962–963
Puri VN (1980) Urinary levels of ADH in nocturnal enuresis. Indian Pediatrics 17:675–678
Puri VN (1986) Increased urinary antidiuretic hormone secretion by imipramine. Experimental and Clinical Endocrinology 88:112–114
Ramsden PD, Hindmarsh JR, Price DA, Yeates WK, Bowditch JDP (1982) DDAVP for adult enuresis — a preliminary report. British Journal of Urology 54:256–258
Rew DA, Rundle JSH (1989) Assessment of the safety of regular DDAVP therapy in primary nocturnal enuresis. Urology 63:352–353
Rittig S, Knudsen UB, Nörgaard JP, Pedersen EB, Djurhuus JC (1989a) Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. American Journal of Physiology 256:664–671
Rittig S, Knudsen UB, Sörensen S, Djurhuus JC, Nörgaard JP (1989b) Long-term double-blind cross-over study of desmopressin intranasal spray in the management of nocturnal enuresis. In: Meadow SR (ed) Desmopressin in nocturnal enuresis (pp. 43–55). Horus Medical Publications, Canwell, England
Rushton HG (1989) Nocturnal enuresis: epidemiology, evaluation, and currently available treatment options. Journal of Pediatrics 114 (Supplement):691–696
Schmitt BD (1990) Efficacy and safety of drugs available for the treatment of nocturnal enuresis. Drug Investigation 2 (Supplement 5):9–16
Segni G, Salvaggio E, Parenti D, Cataldi L, Auriti C, Rossodivita A, Fano M (1982) New therapeutic prospects in enuresis: desmopressin (DDAVP). Minerva Pediatrica 34:45–52
Shaffer D (1985) Nocturnal enuresis: its investigation and treatment. In: Shaffer D, Ehrhardt AA, Greenhill L (eds) The Clinical Guide to Child Psychiatry (pp. 29–47). The Free Press, New York
Spitzer RL, Williams JBW (1987) Quick reference to the diagnostic criteria from DSM-III-R. American Psychiatric Association, Washington
Stegner H (1988) Personal communication
Stegner H, Dittmann RW, Steen S, Commentz JC (1986). DDAVP (desmopressin) treatment in primary enuresis nocturna. Acta Endocrinologica 108 (Supplement 274)
Sukhai RN, Mol J, Harris AS (1989) Combined therapy of enuresis alarm and desmopressin in the treatment of nocturnal enuresis. European Journal of Paediatrics 148:465–467
Tausch A, Stegner H, Leake R, Artman HG, Fisher DA (1983) Radioimmuno-assay of arginine vasopressin in urine. Journal of Clinical Endocrinology and Metabolism 57:777
Terho P (1991) Desmopressin in nocturnal enuresis. Journal of Urology 138:818–820
Terho P, Kekkomäki M (1984) Management of nocturnal enuresis with a vasopressin analogue. Journal of Urology 131:925–927
Tuvemo T (1978) DDAVP in childhood nocturnal enuresis. Acta Paediatrica Scandinavica 67:753–755
Vilhardt H (1989) Pharmacology of desmopressin. In: Meadow SR (ed) Desmopressin in nocturnal enuresis (pp. 26–28). Horus Medical Publications, Canwell, England
Vilhardt H (1990) Basic pharmacology of desmopressin. A review. Drug Investigation 2 (Supplement 5):2–8
Ware JA (1990) Introduction. Sect 2. Drug Investigation 2 (Supplement 5):24
Wille S (1986) Comparison of desmopressin and enuresis alarm for nocturnal enuresis. Archives of Disease in Childhood 61:30–33
Wille S (1989) Comparison of desmopressin and enuresis alarm for nocturnal enuresis. In: Meadow SR (ed) Desmopressin in nocturnal enuresis (pp. 35–42). Horus Medical Publications, Canwell, England
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dittmann, R.W., Wolter, S. Primary nocturnal enuresis and desmopressin treatment: Do psychosocial factors affect outcome?. European Child & Adolescent Psychiatry 5, 101–109 (1996). https://doi.org/10.1007/BF01989502
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01989502